FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

386880006: Zafirlukast (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461058012 Zafirlukast (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1480994011 Zafirlukast en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zafirlukast Is a Substance with leukotriene receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Zafirlukast Has disposition Leukotriene receptor antagonist true Inferred relationship Existential restriction modifier
Zafirlukast Is a Drug allergen false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing zafirlukast Has active ingredient True Zafirlukast Inferred relationship Existential restriction modifier 1
Product containing precisely zafirlukast 20 milligram/1 each conventional release oral tablet Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Product containing precisely zafirlukast 10 milligram/1 each conventional release oral tablet Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Product containing precisely zafirlukast 20 milligram/1 each conventional release oral tablet Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier 1
Product containing precisely zafirlukast 20 milligram/1 each conventional release oral tablet Has basis of strength substance True Zafirlukast Inferred relationship Existential restriction modifier 1
Product containing precisely zafirlukast 10 milligram/1 each conventional release oral tablet Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier 1
Product containing precisely zafirlukast 10 milligram/1 each conventional release oral tablet Has basis of strength substance True Zafirlukast Inferred relationship Existential restriction modifier 1
Product containing zafirlukast in oral dose form (medicinal product form) Has active ingredient True Zafirlukast Inferred relationship Existential restriction modifier 1
Product containing precisely zafirlukast 20 milligram/1 each conventional release oral tablet Has precise active ingredient True Zafirlukast Inferred relationship Existential restriction modifier 1
Product containing precisely zafirlukast 10 milligram/1 each conventional release oral tablet Has precise active ingredient True Zafirlukast Inferred relationship Existential restriction modifier 1
Zafirlukast Has active ingredient True Zafirlukast Inferred relationship Existential restriction modifier 1
Product containing only zafirlukast in oral dose form (medicinal product form) Has active ingredient True Zafirlukast Inferred relationship Existential restriction modifier 1
Zafirlukast 20mg tablet - product Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablet Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Product containing precisely zafirlukast 20 milligram/1 each conventional release oral tablet Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets (Special Order) 1 tablet Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets (Special Order) Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 1 tablet Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (AstraZeneca) Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (PI) (Waymade Ltd) Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (PI) (Dowelhurst Ltd) Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (AstraZeneca) 56 tablet 4 x 14 tablets Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (PI) (Waymade Ltd) 56 tablet 4 x 14 tablets Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (PI) (Dowelhurst Ltd) 56 tablet 4 x 14 tablets Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Doncaster Pharmaceuticals Ltd) Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Sigma Pharmaceuticals Plc) 56 tablet Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (AstraZeneca) Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (PI) (Dowelhurst Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (PI) (Waymade Ltd) Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (AstraZeneca) 56 tablet 4 x 14 tablets Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (PI) (Waymade Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Doncaster Pharmaceuticals Ltd) Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Product containing precisely zafirlukast 20 milligram/1 each conventional release oral tablet Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Sigma Pharmaceuticals Plc) 56 tablet Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (PI) (Dowelhurst Ltd) Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Has active ingredient False Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Has specific active ingredient True Zafirlukast Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start